The Federal Circuit reversed a district court’s reduction of an $82 million jury verdict for breach of contract to just $3, and held that trade secret plaintiffs have a statutory right to pursue unjust enrichment damages under both the DTSA and Michigan’s trade secrets act.
The Federal Circuit affirmed the PTAB’s finding that all 17 claims of Pictometry’s patent on measuring roofs from aerial imagery are unpatentable as obvious over prior art combining roof-measurement and marker-locking references.
The Federal Circuit affirmed the PTAB’s finding that all claims of a synchronized-browsing patent were unpatentable as obvious, rejecting the patent holder’s bid to narrowly construe the key claim term “web browsing interaction data.”
The Federal Circuit affirmed that Lupin’s generic tolvaptan manufacturing process does not infringe Otsuka’s patents and that certain synthesis method claims are obvious, clearing the way for a generic version of the kidney disease drug JYNARQUE®.
The Federal Circuit reversed a dismissal for lack of standing, holding that a patent owner who grants an exclusive license but retains the right to sue, a sublicensing veto, and royalty interests retains a sufficient exclusionary right for Article III standing.
In a companion case to ALM Holding v. Zydex, the Federal Circuit held that Medtronic Ireland retained Article III standing to assert patent infringement counterclaims despite licensing exclusive rights to an affiliate, because it kept the right to sue, sublicensing veto, and royalty interests.
In a precedential opinion, the Federal Circuit reversed a Delaware district court’s dismissal for lack of standing, holding that patent owners who retain the right to sue for infringement, a sublicensing veto, and royalty interests maintain Article III standing even after granting a broad excl
The full Federal Circuit denied en banc rehearing of its February 2026 panel decision affirming a $71.4 million verdict for infringement of Willis Electric’s pre-lit Christmas tree connector patent, rejecting Polygroup’s challenge to the damages expert methodology.
The Federal Circuit affirmed dismissal of a patent infringement case involving a unified electronic banking system, finding surviving claims obvious in light of an IPR outcome, but reversed both the exceptional-case attorney fee award and sanctions against counsel, holding that mere invalidity is in
The Federal Circuit affirmed that Actelion’s patent claims requiring a bulk solution with ‘a pH of 13 or higher’ refer to pH measured at standard temperature (25±2°C), not at the solution’s actual operating temperature, finding no literal or equivalent infringement by Mylan&#